Zomedica is dedicated to enhancing animal health and supporting veterinarians through innovative technologies and products. Their diagnostic suite, ZOM•Dx, is designed to streamline the diagnostic process, improving efficiency from sample collection to result analysis. This technology aims to empower veterinary practitioners by providing them with tools that enhance their diagnostic capabilities, ultimately leading to better patient outcomes. Additionally, Zomedica offers advanced therapeutic solutions, such as Assisi's tPEMF therapy, which has been successfully used to treat over 50,000 pets, addressing issues like pain, inflammation, and anxiety.

Furthermore, Zomedica is at the forefront of regenerative medicine with PulseVet, a leader in shock wave therapy for veterinary applications. This technology is backed by over 20 years of clinical research, demonstrating its effectiveness in promoting accelerated healing in animals. The PulseVet Shock Wave System, along with its specialized components like the X-Trode™ and Equine Trode Set, showcases Zomedica's commitment to providing cutting-edge solutions that enhance the quality of care veterinarians can offer. Through these innovative technologies, Zomedica aims to support both animal health and the success of veterinary practices.

United States

Zomedica is a veterinary pharmaceutical and health care solutions company creating innovative products for companion animals (canine, feline and equine).

Zomedica

Company Details